Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 175-182
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.175
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.175
Figure 1 Adjusted hazard ratio for hepatocellular carcinoma by serum hepatitis B virus DNA levels at study entry and last follow-up.
Data were adjusted for gender, age, cigarette smoking and alcohol consumption using Cox proportional hazards model. HCC: hepatocellular carcinoma; HBV: Hepatitis B virus. Data sourced from Chen et al[11].
- Citation: Fernández-Rodríguez CM, Gutiérrez-García ML. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther 2014; 5(3): 175-182
- URL: https://www.wjgnet.com/2150-5349/full/v5/i3/175.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v5.i3.175